U.K. Productivity Worst Since Industrial Revolution, BOE Says
(Bloomberg) -- Britons were only beginning to use steam engines, canals and factories the last time the U.K. experienced such a poor decade of productivity.
Total factor productivity since 2007 was the worst since the late eighteenth century, around the time of the industrial revolution, according to a Bank of England blog post Wednesday.
Average productivity growth was negative for the first time in almost a century, BOE researcher John Lewis said.
“Whatever the cause, productivity growth over the past decade has been remarkably poor by most historical standards,” he said.
Output per worker in the U.K. has failed to recover its pre-crisis trend, eating into the economy's potential growth rate. Possible explanations include the U.K.'s current reliance on services, which lag manufacturing in terms of efficiency growth, “zombie” firms that have been kept alive by loose monetary policy, and limits in the flow of people between companies.
Poor productivity also explains why pay has remained subdued, despite the lowest unemployment in more than four decades. BOE Governor Mark Carney said in 2016 that real wage growth over the previous decade was the slowest since the mid-nineteenth century.
While productivity growth picked up in the second half of 2017, officials at the BOE and the Treasury urge caution. Some economists say Brexit could exacerbate the problem, since reducing trade with the European Union risks curbing productivity-enhancing innovation and investment.
To contact the reporter on this story: Jill Ward in London at jward98@bloomberg.net.
To contact the editors responsible for this story: Fergal O'Brien at fobrien@bloomberg.net, Andrew Atkinson, David Goodman
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.